Antipsychotics: A real or confounding risk factor for venous thromboembolism?

Pharmacopsychiatry

Volumn 46, Issue 1, 2013, Pages 36-37

  Chapelle, C ^a   Quenet, S ^b   Delavenne, X ^a,b   Lacut, K ^c   Mismetti, P ^a,b   Laporte, S ^a,b   Beyens, M N ^a,b  

^a UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^b University Jean Monnet of Saint Etienne EA3065   (France)

^c UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

Author keywords

antipsychotics; meta analysis; observational studies; venous thromboembolism

Indexed keywords

NEUROLEPTIC AGENT;

ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; DISEASE ASSOCIATION; DRUG EXPOSURE; HIGH RISK PATIENT; HUMAN; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RISK FACTOR; VENOUS THROMBOEMBOLISM;

ANTIPSYCHOTIC AGENTS; CASE-CONTROL STUDIES; HUMANS; META-ANALYSIS AS TOPIC; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 84872681481     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0032-1316347     Document Type: Article

References (4)

1. Zhang R., Dong L., Shao F. Antipsychotics and venous thromboembolism risk: a meta-analysis. Pharmacopsychiatry: 2011; 44 183 188
2. NHMRC levels of evidence and grades for recommendations for developers of guidelines: 2009; Available from: http://www.nhmrc.gov.au/-files-nhmrc/file/ guidelines/evidence-statement-form.pdf
3. Ray J. G., Mamdani M. M., Yeo El. Antipsychotic and antidepressant drug use in the elderly and the risk of venous thromboembolism. Thromb Haemost: 2002; 88 205 209 (Pubitemid 34873699)
4. Liperoti R., Pedone C., Lapane K. L. Venous thromboembolism among elderly patients treated with atypical and conventional antipsychotic agents. Arch Intern Med: 2005; 165 2677 2682 (Pubitemid 41785068)